m+Medelevator.RU
← Поиск публикаций
Lancet regional health. Americas · 2025

World Health Organization priority antimicrobial resistance in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecium healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational study.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Antochevis Laura C, Wilhelm Camila M, Arns Beatriz, Sganzerla Daniel, Sudbrack Letícia O, Nogueira Thais C R L, Guzman Ricardo D, Martins Amanda S, Cappa Daniela S, Dos Santos Ândrea C, Pascual Joseani C, Perugini Vitor Hugo, Vespero Eliana C, Rigatto Maria Helena P, Pereira Dariane C, Lutz Larissa, Leão Robson S, Marques Elizabeth A, Henrique Danielle M, Coelho André A M, Frutuoso Lígia L, de A Sousa Erika E, Abreu Guimarães Luiz F, Ferreira Adriana L P, Castiñeiras Anna Carla, Alves Marcelle D, Telles João Paulo, Yamada Carolina H, de Almeida Francieli P, Girão Evelyne S, de Sousa Paulo C P, de Melo Antonio G N D, Mendes Elisa T, Rocha Verônica de F D, Neves Euclimeire da S, Ribeiro Marcello T, Starling Carlos Ernesto Ferreira, Oliveira Maura S, Sampaio Jorge L M, Martins Andreza F, Barth Afonso L, Zavascki Alexandre P, ASCENSION Study Group

Аннотация

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE), Acinetobacter baumannii (CRAB), Pseudomonas aeruginosa (CRPA), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE) are listed by World Health Organization (WHO) as priority antimicrobial-resistant bacteria. Data on WHO Priority Antimicrobial resistance Phenotype (WPAP) bacteria from low- and middle-income countries are scarce. In this study, we investigated the occurrence of WPAP in healthcare-associated bloodstream infections (BSI) in Brazil, an upper-middle-income country in South America.

METHODS: ASCENSION was a prospective, multicentre, observational study conducted in 14 hospitals from four of five Brazilian regions. Enterobacterales, A. baumannii, P. aeruginosa, S. aureus and E. faecium BSIs in hospitalised patients were analysed. The primary outcome was the frequency of WPAP among all bacteria of interest. Secondary outcomes were incidence-density of bacteria isolates in hospitalised patients, WPAP proportions within bacterial species, and 28-day mortality. PCR for carbapenemase genes was performed in carbapenem-resistant Gram-negative bacteria.

FINDINGS: Between August 15, 2022, and August 14, 2023, 1350 isolates (1220 BSI episodes) were included. WPAP accounted for 38.8% (n = 524; 95% Confidence Interval 32.0-46.1) of all isolates, with CRE (19.3%) as the most frequent, followed by CRAB (9.6%), MRSA (4.9%), VRE (2.7%), and CRPA (2.4%). Incidence-density of all and WPAP isolates were 1.91 and 0.77/1000 patients-day, respectively. Carbapenem-resistant Klebsiella pneumoniae (CRKP) was the most common CRE, corresponding to 14.2% of all BSIs. A. baumannii isolates presented the highest proportion of WPAP (87.8%). Mortality rates were higher in patients with BSIs by WPAP than non-WPAP isolates. KPC (64.4%) was the predominant carbapenemase in CRE, followed by NDM (28.4%) and KPC + NDM co-production (7.1%). OXA-23 was the most frequent in CRAB.

INTERPRETATION: A high frequency of WPAP bacteria, particularly CRKP and CRAB, were found in healthcare-associated BSIs in Brazil, posing them as a major public health problem in this country.

FUNDING: National Council for Scientific and Technological Development, Brazil.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты